Twin to twin transfusion syndrome is a serious pregnancy complication that affects identical twins who share one placenta. It can cause one baby to have too little blood and fluid, while the other has too much, so growth and heart strain can develop. Many people first hear about twin to twin transfusion syndrome during an ultrasound after signs such as uneven growth or very different amniotic fluid levels are seen. It develops during pregnancy and can become dangerous without treatment, with risks including preterm birth, pregnancy loss, or death of one or both babies. Treatment often includes close monitoring, drainage of extra fluid, and a laser procedure to seal abnormal blood vessel connections in the placenta.
How many people live with Twin to twin transfusion syndrome?
Because twin-to-twin transfusion syndrome happens during pregnancy, estimates are usually given as affected pregnancies each year rather than people living with it: based on about 1.6 million twin pregnancies worldwide and the fact that about 10% to 15% of twin pregnancies where both babies share one placenta develop TTTS, roughly 32,000 to 48,000 pregnancies worldwide may be affected each year (Monden et al., 2021; StatPearls, 2023). Using U.S. birth data and the same 10% to 15% range, roughly 1,100 to 1,700 pregnancies in the United States may be affected each year, which is an estimate rather than a direct national count (CDC, 2024; StatPearls, 2023).
Overview
Twin to twin transfusion syndromeSymptoms
Twin to twin transfusion syndrome often has no clear symptoms at first. Some pregnant people notice a rapidly growing belly, sudden weight gain, tightness, or contractions. On ultrasound, one twin may have too much fluid and the other too little.
Outlook and prognosis
Twin-to-twin transfusion syndrome can be serious, but outcomes have improved greatly with close monitoring and laser treatment during pregnancy. Prognosis depends on how early it is found, the stage, and how both babies respond before birth.
Causes and risk factors
Twin to twin transfusion syndrome happens when identical twins share one placenta with uneven blood vessel connections. The main risk factor is a monochorionic pregnancy; it is not caused by anything a parent did, ate, or avoided.
Genetic influences
For twin to twin transfusion syndrome, genetics do not seem to be a main cause. It is usually linked to how the shared placenta develops, not to inherited genetic variations.
Diagnosis
Twin to twin transfusion syndrome is usually suspected on ultrasound during pregnancy. Doctors look for unequal amniotic fluid, bladder size, and twin growth. Diagnosis is confirmed with repeated ultrasound and blood-flow checks.
Treatment and drugs
Twin to twin transfusion syndrome is treated during pregnancy with close ultrasound monitoring, and some pregnancies need amnioreduction or fetoscopic laser surgery to seal shared placental blood vessels. Early delivery may also be recommended.
Symptoms
In a shared-placenta twin pregnancy, twin to twin transfusion syndrome can make the pregnancy feel more uncomfortable much faster than expected. The early symptoms of twin to twin transfusion syndrome can be easy to miss because some changes feel like a twin pregnancy suddenly becoming more intense. You might notice small changes at first, but many cases are first picked up on ultrasound before there are clear symptoms. When symptoms do happen, they often relate to rapid extra fluid buildup and stretching of the uterus.
Your abdomen may seem to grow noticeably over a few days rather than gradually over weeks. Pants may feel tighter, and simple things like getting out of bed or bending forward can become harder.
The belly can feel very stretched, firm, or uncomfortable because the uterus is expanding quickly. Some people also notice pelvic pressure, low back pain, or a heavy feeling.
Extra fluid and a rapidly enlarging uterus can press upward and make it harder to take a deep breath. Climbing stairs, lying flat, or walking across a room may suddenly feel more tiring.
Rapid stretching of the uterus can trigger cramping, tightening, or contractions, sometimes leading to signs of preterm labor. In twin to twin transfusion syndrome, new contractions should be checked urgently.
How people usually first notice Twin to twin transfusion syndrome?
Twin to twin transfusion syndrome is usually first noticed during pregnancy, not because the pregnant person feels a specific symptom, but because an ultrasound shows one identical twin surrounded by too much amniotic fluid while the other has too little. These first signs of Twin to twin transfusion syndrome may also include one twin looking much larger or more active, while the other appears smaller, with a less visible bladder or slower growth. Sometimes the pregnant person may notice a belly that seems to grow very quickly, tightness, contractions, or shortness of breath, but in many cases doctors first spot the pattern at a routine prenatal scan.
Types of Twin to twin transfusion syndrome
Twin to twin transfusion syndrome can change a lot from one pregnancy to another, and the main differences are based on how severe it has become. When people ask about the types of twin to twin transfusion syndrome, doctors usually mean its stages rather than separate diseases. Symptoms don’t always look the same for everyone. The most widely used system is called the Quintero staging system, which helps describe how blood flow imbalance is affecting each twin.
Stage I
One twin has extra fluid around them, while the other has too little, but the smaller twin’s bladder can still be seen on ultrasound. This is the mildest recognized stage, although it still needs close specialist follow-up.
Stage II
The smaller twin’s bladder is no longer seen on ultrasound, which suggests blood flow problems are becoming more significant. Fluid imbalance is still present, and many living with twin to twin transfusion syndrome will need careful monitoring or treatment planning at this point.
Stage III
Abnormal blood flow now shows up in one or both twins on Doppler ultrasound, a scan that looks at how blood moves through certain vessels. This stage points to more serious strain on the babies and a higher risk of complications if the condition worsens.
Stage IV
One or both twins develop signs of heart strain severe enough to cause fluid buildup in the body, called hydrops. This is an advanced form of twin to twin transfusion syndrome and usually requires urgent specialist care.
Stage V
One twin dies in the womb, which is the most severe stage of twin to twin transfusion syndrome. Even at this stage, the surviving twin still needs immediate expert assessment because risks can remain high.
Can I slow down the onset of symptoms?
Usually, no: there is no good evidence that diet, activity, bed rest, vitamins, or other lifestyle changes can meaningfully delay twin-to-twin transfusion syndrome, because it happens when identical twins share one placenta and the blood flow between them becomes uneven. What does help is early, regular ultrasound monitoring in pregnancies where twins share a placenta, since standard specialist care can catch changes early and, if needed, offer treatment to manage the problem, but that is not the same as preventing it from starting. Staying closely connected with your pregnancy team gives the best chance of finding problems quickly and improving outcomes, even though no step can guarantee prevention.
What genetics can tell you about symptoms
For twin-to-twin transfusion syndrome, genetics usually does not tell you much about which symptoms will happen, how severe they will be, or when they will start. This condition is mainly caused by the way identical twins share a placenta and the blood vessel connections within it, so symptoms and severity are driven much more by placental blood flow than by inherited gene changes. In some pregnancies, doctors may still look closely at genetics to check for other, separate conditions that can affect growth or fluid levels, but that is not what usually causes twin-to-twin transfusion syndrome itself.
Causes and risk factors
In a pregnancy with twins who share one placenta, blood flow can become uneven, and this can lead to twin to twin transfusion syndrome. The problem comes from blood vessel connections in the placenta that let one twin give away too much blood while the other gets too much. The main biological risk factor is a shared placenta, which is most often seen in identical twins. There is no clear inherited genetic cause, and most risk factors for twin to twin transfusion syndrome are tied to the placenta rather than to diet, exercise, stress, or other everyday exposures. Risk can vary widely from person to person, so these pregnancies need close ultrasound follow-up.
What are the most common causes or risk factors?
The main cause of twin-to-twin transfusion syndrome is a twin pregnancy where identical twins share one placenta, because blood vessels inside that shared placenta can connect in a way that sends too much blood to one baby and too little to the other. The biggest risk factor is simply having twins, or sometimes higher-order multiples, that share a placenta; this does not happen in twins with separate placentas. It is not thought to be caused by anything a parent did during pregnancy, and family history or inherited genes are not known to be major risk factors.
Environmental and biological risk factors
Twin to twin transfusion syndrome, often shortened to TTTS, develops only in certain shared-placenta twin pregnancies. Some risks are carried inside the body, others come from the world around us. For TTTS, the well-established risk factors are mostly biological and relate to how the placenta and its blood vessels formed.
TTTS can happen only when the babies share one placenta, which is called a monochorionic pregnancy. This is the main biological setting that makes twin to twin transfusion syndrome possible.
The risk goes up when blood vessels in the shared placenta connect in a way that lets blood flow unevenly between the twins. Not every shared placenta has this pattern, which is why some monochorionic twin pregnancies do not develop TTTS.
Some shared placentas are divided unevenly, so one twin has less placental territory than the other. This can increase the likelihood of twin to twin transfusion syndrome, especially when unbalanced vessel connections are also present.
TTTS can also occur in triplet or higher-order pregnancies if two fetuses share a placenta. The key risk is still the same shared placental structure and connected blood vessels.
Genetic risk factors
For families facing twin to twin transfusion syndrome, it is natural to wonder whether it was passed down through genes. When doctors look at the genetic causes of twin to twin transfusion syndrome, they usually do not find a single inherited gene behind it. Instead, twin to twin transfusion syndrome becomes possible when identical twins share one placenta and have blood vessel connections between them. Risk is not destiny—it varies widely between individuals.
Shared placenta: Twin to twin transfusion syndrome can only happen when babies share a single placenta, most often in identical twin pregnancies. That shared placenta creates the setting where blood vessel links can form between the twins.
Vessel imbalance: The direct cause is an uneven pattern of blood vessel connections inside the shared placenta. If blood tends to flow more strongly in one direction, one twin may give away too much blood while the other receives too much.
No proven gene: Researchers have not found one inherited gene change that clearly explains most cases of twin to twin transfusion syndrome. Most affected pregnancies happen without a clear genetic disorder in either parent or baby.
Family history: Twin to twin transfusion syndrome does not usually run in families in a simple inherited way. Even if twins are present in a family, that alone does not mean a future pregnancy will have this condition.
Lifestyle risk factors
Twin to twin transfusion syndrome is not caused by a pregnant person's lifestyle, but daily habits can still influence maternal well-being, early recognition of problems, and the course of a high-risk monochorionic twin pregnancy. When people ask about lifestyle risk factors for twin to twin transfusion syndrome, the most accurate answer is that lifestyle does not create the abnormal placental vessel connections, yet it can affect hydration, symptom monitoring, fetal growth support, and readiness for treatment. Healthy routines should always be individualized with a maternal-fetal medicine specialist, especially if TTTS is suspected or confirmed.
Missing prenatal visits can delay ultrasound detection of fluid imbalance, growth changes, or cardiac strain in the twins. Keeping frequent specialist appointments improves the chance of finding progression early and planning laser treatment or other interventions promptly.
Poor fluid intake may worsen maternal fatigue, dizziness, and discomfort in pregnancies already stressed by rapid uterine enlargement. Good hydration does not prevent TTTS, but it may support maternal circulation and help someone better tolerate symptoms and monitoring.
Smoking or nicotine exposure can reduce oxygen delivery and worsen placental dysfunction in an already fragile twin pregnancy. This may add fetal growth stress and increase the risk of poorer outcomes alongside TTTS.
Alcohol and non-prescribed drugs do not cause TTTS, but they can impair fetal development and complicate assessment of growth and neurologic well-being. Avoiding them is important because additional fetal stress can make management of TTTS more difficult.
Risk prevention
Twin to twin transfusion syndrome can happen in identical twins who share one placenta, and there is no proven way to fully prevent it once that placental setup is present. What helps most is finding a shared placenta early and watching the pregnancy closely so changes are caught as soon as possible. Prevention is about lowering risk, not eliminating it completely. For many families, this means specialized prenatal care rather than anything they did or did not do.
An early pregnancy ultrasound can show whether twins share one placenta, which is the main setting where twin to twin transfusion syndrome develops. Knowing this early helps the care team plan the right follow-up.
Frequent ultrasounds in a monochorionic twin pregnancy can pick up fluid changes, growth differences, and other early signs of twin to twin transfusion syndrome before serious problems build. Many living with this risk are monitored more often than in a typical twin pregnancy.
Seeing a maternal-fetal medicine specialist can lower the chance that important warning signs are missed. These teams know when closer monitoring, laser treatment, or early delivery may be safest.
Between visits, sudden belly enlargement, fast weight gain from excess amniotic fluid, contractions, or feeling unusually short of breath should be reported promptly. These symptoms do not always mean twin to twin transfusion syndrome, but they need quick assessment.
Can you prevent Twin to twin transfusion syndrome?
No, twin-to-twin transfusion syndrome usually cannot be prevented, because it happens when twins who share one placenta develop unbalanced blood flow through blood vessel connections that no one can control. The best step is not prevention but early detection: if you are carrying twins who share a placenta, regular prenatal visits and ultrasound checks with a specialist can help find problems early and improve care.
Transmission
Twin to twin transfusion syndrome is not an infection, so it cannot spread from one pregnant person to another, from parent to child after birth, or through contact, الهواء, food, or sex. It develops during pregnancy only when identical twins share one placenta and the blood flow between them becomes uneven through connecting blood vessels.
If you are wondering how Twin to twin transfusion syndrome is inherited, it usually is not inherited at all and is not thought to run in families in the usual way. For most families, this means Twin to twin transfusion syndrome happens because of how the shared placenta forms in that pregnancy, not because anyone passed on a disease or did something wrong.
When to test your genes
Twin-to-twin transfusion syndrome is not a genetic condition, so gene testing does not help with early detection or guide treatment. What matters is early ultrasound monitoring in any monochorionic twin pregnancy, usually starting in the first trimester and repeated regularly to watch fluid levels, growth, and blood flow.
Diagnosis
Twin to twin transfusion syndrome is usually found during pregnancy monitoring when identical twins share one placenta and ultrasound starts to show an uneven blood flow pattern between them. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of twin to twin transfusion syndrome mainly relies on repeat ultrasound exams, along with other tests that show how each baby is growing and coping in the womb.
Doctors usually begin with an ultrasound to confirm that the twins share one placenta and are in separate amniotic sacs. This is the key starting point for how twin to twin transfusion syndrome is diagnosed during pregnancy.
A major clue is a large difference in amniotic fluid around the twins. One baby may have very low fluid and look pressed against the uterine wall, while the other may have too much fluid.
On ultrasound, the smaller donor twin may have a bladder that is hard to see because it is making less urine. The larger recipient twin often has a clearly visible bladder, which supports the diagnosis when seen with fluid differences.
The care team also checks whether one twin is much smaller than the other and measures each baby over time. These findings do not confirm twin to twin transfusion syndrome on their own, but they help show how severe the imbalance may be.
How is Twin to twin transfusion syndrome diagnosed?
Twin-to-twin transfusion syndrome is usually diagnosed during pregnancy with ultrasound in identical twins sharing one placenta. Doctors look for a pattern where one baby has very little amniotic fluid and may seem pressed against the wall of the womb, while the other has too much fluid, and they may also check each baby’s bladder, growth, and blood flow to see how serious it is. Genetic testing is not usually used to diagnose this condition.
Stages of Twin to twin transfusion syndrome
Twin to twin transfusion syndrome has recognized progression stages, most often described with the Quintero staging system. These stages are based on ultrasound findings, not just on how the pregnancy feels day to day, so early symptoms of twin to twin transfusion syndrome may be subtle or absent. In many pregnancies, the stage can change over time, which is why close monitoring with repeated scans is so important.
Stage I
The donor twin has less amniotic fluid, and the recipient twin has too much. The donor twin’s bladder is still seen on ultrasound, which suggests blood flow imbalance is present but not yet at a more severe stage.
Stage II
The donor twin’s bladder is no longer clearly seen during the ultrasound exam. This suggests the donor twin is making very little urine because of reduced blood flow.
Stage III
Blood flow changes appear in one or both twins on Doppler ultrasound. This means the circulation is under more strain and the risk to the pregnancy is higher.
Stage IV
One or both twins develop signs of heart failure, causing fluid to build up in the body. This is called hydrops and is a sign that twin to twin transfusion syndrome has become severe.
Stage V
One or both twins die in the womb. This is the most advanced stage and requires urgent specialist care and support.
Outlook and prognosis
The outlook for twin to twin transfusion syndrome depends mainly on how early it is diagnosed, how severe it is, and whether treatment such as fetoscopic laser therapy is available. Without treatment, severe cases carry a high risk of losing one or both babies, while modern treatment has substantially improved survival, with at least one twin surviving in most treated pregnancies and both twins surviving in many cases. Even when the babies survive, there remains a risk of prematurity, growth problems, and neurologic complications, especially in more advanced stages. Long-term outcomes are often good for survivors who are treated promptly, but careful follow-up is important because developmental or motor problems can occur in a minority of children. The mother usually does well physically after delivery, although the pregnancy often requires intensive monitoring and may end earlier than expected. Overall, prognosis has improved markedly in recent years, but twin to twin transfusion syndrome is still a serious condition that can be life-threatening for the fetuses.
Long-term effects
Twin to twin transfusion syndrome can have lasting effects for one or both twins, but the outlook varies a lot depending on how severe it was, when it was found, and whether treatment worked. Some children do very well after birth, while others may need follow-up for problems linked to prematurity, reduced blood flow, or strain on the heart before delivery. Long-term effects vary widely, and not every baby affected by twin to twin transfusion syndrome will have ongoing health problems. Thinking about the long-term effects helps families understand why doctors may recommend developmental and medical follow-up over time.
Many babies with twin to twin transfusion syndrome are born early, and prematurity itself can shape long-term health. For many, this can mean breathing problems, feeding challenges, or slower growth in infancy and early childhood.
Reduced or uneven blood flow before birth can raise the risk of brain injury in some twins. Later on, this may show up as learning difficulties, delays in early milestones, or movement problems such as cerebral palsy.
The recipient twin may have had extra fluid and blood volume before birth, which can put stress on the heart. Some children need long-term follow-up for heart muscle thickening, valve problems, or ongoing changes in heart function.
One or both twins may grow more slowly after a pregnancy affected by twin to twin transfusion syndrome. Many people notice small adjustments like closer tracking of weight, height, and feeding, especially when one twin was much smaller at birth.
How is it to live with Twin to twin transfusion syndrome?
Living with twin-to-twin transfusion syndrome can feel like a pregnancy that suddenly becomes much more medical, with frequent ultrasounds, specialist visits, and ongoing uncertainty as doctors watch both twins closely. For many pregnant people, this can mean more stress, activity limits in some cases, possible procedures, and the emotional strain of balancing hope with fear while symptoms such as rapid abdominal growth, discomfort, or shortness of breath may appear. The effects often reach the whole family, because partners, loved ones, and other children may need to adjust routines, offer practical help, and cope with the anxiety that comes with a high-risk pregnancy.
Treatment and drugs
Twin to twin transfusion syndrome is treated by closely monitoring the pregnancy with frequent ultrasound scans, because care depends on how severe the imbalance in blood flow is and how far along the pregnancy is. In milder cases, the care team may watch growth, amniotic fluid levels, and blood flow patterns, while more serious Twin to twin transfusion syndrome often needs treatment during pregnancy. The main treatment is usually a minimally invasive procedure called fetoscopic laser surgery, which seals the blood vessel connections in the placenta that are causing the problem. In some situations, doctors may also remove extra amniotic fluid to relieve pressure, and if the babies are far enough along or either twin is becoming unstable, early delivery may be the safest option. Not every treatment works the same way for every person, so care is usually guided by a maternal-fetal medicine specialist with experience in Twin to twin transfusion syndrome.
Can you cure Twin to twin transfusion syndrome?
There is no guaranteed cure for twin-to-twin transfusion syndrome, but doctors can sometimes treat the main problem during pregnancy. The most effective treatment is a procedure that uses a tiny camera and laser to close the blood vessel connections in the shared placenta that are causing the uneven blood flow, and some pregnancies are managed with close monitoring, removal of extra amniotic fluid, or early delivery. Even with treatment, there can still be serious risks for one or both babies, so care from a high-risk pregnancy team is very important.
Non-drug treatment
Twin to twin transfusion syndrome can change a pregnancy quickly, so non-drug care usually focuses on protecting both babies and watching for problems early. For many, treatment begins not at the pharmacy, but with urgent care from a maternal-fetal medicine team and regular ultrasound checks. The best approach depends on how severe the condition is, how far along the pregnancy is, and how each twin is doing. In many pregnancies, early treatment for twin to twin transfusion syndrome can improve the chances of a healthier outcome.
Frequent ultrasounds are a core part of care for twin to twin transfusion syndrome. They track each baby's growth, amniotic fluid levels, blood flow, and signs of strain on the heart. This helps the team decide when closer follow-up or a procedure is needed.
Fetoscopic laser treatment is often the main procedure for more severe twin to twin transfusion syndrome. A specialist places a tiny camera into the uterus and seals the shared blood vessels causing the imbalance. This aims to separate the twins' circulation and reduce ongoing harm.
In some pregnancies, doctors remove extra amniotic fluid from around the recipient twin with a needle, a procedure called amnioreduction. This can lower pressure in the uterus and may ease symptoms such as rapid belly growth or shortness of breath. It does not fix the shared blood vessel problem, but it may help in selected situations.
A procedure called septostomy is used much less often today. It creates a small opening in the membrane between the twins so fluid can move more freely. Doctors usually reserve it for specific cases because it can bring added risks.
Your genes may have an impact on how drugs work for you
For twin-to-twin transfusion syndrome, treatment usually depends much more on the stage of the condition and the babies’ blood flow than on inherited differences in how medicines work. Many living with this condition are treated with close monitoring, procedures done during pregnancy, and sometimes medicines linked to preterm labor or delivery, but there is no well-established genetic testing used in routine care to guide those medication choices. In other words, for TTTS, a person’s genes are not currently a main factor doctors use when deciding on treatment.
Pharmacological treatments
In twin to twin transfusion syndrome, medicines usually play a supporting role rather than treating the underlying problem itself. The main treatment is typically a procedure such as fetoscopic laser therapy, because no drug can rebalance the abnormal blood flow between the twins. Medication can feel like a big step, but the medicines used for twin to twin transfusion syndrome are most often given to prepare for a procedure, lower short-term risks, or support babies who may need early delivery. Which drugs are used can vary with the stage of TTTS, gestational age, and the treatment plan.
Betamethasone or dexamethasone may be given if there is a high chance of preterm birth. These medicines help the babies’ lungs mature faster and can also lower some risks linked to very early delivery.
Medicines such as nifedipine, indomethacin, or atosiban may be used to calm uterine contractions before or after a fetal procedure. This can help reduce procedure-related cramping and may lower the chance of labor starting too soon.
Magnesium sulfate may be given when very preterm delivery is expected, usually to help protect the babies’ developing brains. It is not a treatment for TTTS itself, but it can be an important part of care in urgent situations.
Local anesthetics such as lidocaine, along with sedating or pain-relieving medicines, are often used during fetoscopic laser treatment. These drugs help keep the pregnant parent comfortable and make the procedure safer and easier to tolerate.
Genetic influences
When one twin receives too much blood and the other too little, twin to twin transfusion syndrome usually reflects how a shared placenta developed rather than a gene passed down through the family. It is natural to ask whether family history plays a role, especially if you are wondering whether twin to twin transfusion syndrome is genetic. In most pregnancies, TTTS is not considered an inherited disorder, and there is no strong evidence that parents carry a specific gene change that directly causes it. The biggest risk factor is having twins that share one placenta, because the blood vessel connections in that placenta can form in an uneven way. If you have had TTTS in a prior pregnancy, the chance of it happening again is mainly linked to the uncommon chance of having another shared-placenta twin pregnancy, not to a strong inherited tendency. Researchers are still studying whether genes may slightly influence placental development, but for now the clearest explanation for TTTS is the placenta itself, not family genetics.
Is Twin to twin transfusion syndrome genetic?
For twin to twin transfusion syndrome, genetics do not seem to be a main cause. It is usually linked to how the shared placenta develops, not to inherited genetic variations.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are common in the general population. Most do not have a direct effect on health and are simply part of normal human diversity. For many genes, having a variant connected to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When twin-to-twin transfusion syndrome is found during pregnancy, treatment decisions are usually guided more by how severe the blood-flow imbalance is, how far along the pregnancy is, and what the ultrasound shows than by genetics. The main treatment, a laser procedure that seals the shared blood vessel connections in the placenta, is chosen based on the placenta’s structure and the babies’ condition, not on a genetic test. Not every difference in response is genetic, but genes can still slightly affect how the pregnant person’s body handles medicines used around treatment, such as anesthesia, pain relief, or drugs that help calm uterine contractions. In practice, routine pharmacogenetic testing is not part of standard care for twin-to-twin transfusion syndrome, because it has not been shown to guide the key treatment choices. For families wondering how genetics affect treatment for twin-to-twin transfusion syndrome, the short answer is that placental blood vessel patterns matter much more than gene differences, while doctors still keep overall medication safety in mind for both the pregnant parent and the babies.
Interactions with other conditions
In daily life, twin to twin transfusion syndrome often does not happen in isolation, and the pregnancy may also be affected by problems such as selective growth restriction, too much or too little amniotic fluid, and preterm labor. The extra blood flow to one twin can strain the heart and raise the risk of fluid buildup in the body, while the other twin may become severely underfilled and grow poorly, so these conditions can build on each other rather than stay separate. Doctors call it a “comorbidity” when two conditions occur together. In some pregnancies, twin to twin transfusion syndrome can overlap with twin anemia-polycythemia sequence, which changes how blood counts look and can affect treatment planning. The pregnancy may also carry a higher risk of complications for the pregnant parent, including high blood pressure disorders such as preeclampsia, especially when the condition is severe. Because these problems can develop quickly, people with twin to twin transfusion syndrome usually need close specialist monitoring so early symptoms of twin to twin transfusion syndrome and related complications are picked up as soon as possible.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Twin to twin transfusion syndrome?
Other problems in a shared-placenta twin pregnancy can look a lot like twin-to-twin transfusion syndrome, especially uneven sharing of the placenta, a blood imbalance between the twins, or a birth difference in one baby that changes the amount of fluid around them. Doctors may also consider other causes of a fast-growing belly, extra fluid, or early contractions, such as too much amniotic fluid for reasons not related to twin-to-twin transfusion syndrome. Ultrasound and close follow-up are usually needed to tell these conditions apart.
History
Twin to twin transfusion syndrome has likely existed as long as identical twins have shared a placenta, but for most of history it was only recognized after birth or after a pregnancy loss. Families and doctors sometimes noticed a puzzling pattern: one twin seemed much smaller and weaker, while the other appeared larger or showed signs of strain. Without modern imaging, it was hard to understand what had happened during the pregnancy.
As medical science evolved, doctors began connecting these uneven outcomes to blood vessel links inside a shared placenta. By the 19th and early 20th centuries, case reports described major differences in twin size, blood volume, and amniotic fluid, even though the full process was not yet clear. Twin to twin transfusion syndrome gradually became the accepted name for this problem, reflecting the idea that blood flow could shift unequally from one twin to the other.
The biggest change came with ultrasound in the late 20th century. For the first time, doctors could watch the pregnancy in real time and spot signs such as one twin being surrounded by too much amniotic fluid while the other had very little. This made early symptoms of twin to twin transfusion syndrome easier to recognize during pregnancy instead of only after delivery, and it helped explain why some parents were told that one baby seemed “stuck” while the other’s sac looked overfilled.
Once the condition could be identified before birth, treatment moved forward quickly. Doctors first used close monitoring and procedures to reduce excess amniotic fluid in some pregnancies. Later, fetal surgery techniques improved, especially laser treatment to seal the abnormal blood vessel connections on the placenta. That shift was a major step, because it aimed to treat the cause of the imbalance rather than only ease its effects.
Today, twin to twin transfusion syndrome is still a serious complication, but outcomes are often much better than they were in the past. Better ultrasound screening, clearer staging systems, and referral to specialist fetal medicine centers have all improved care. Knowing this history helps explain why regular monitoring matters so much in pregnancies where twins share a placenta: the condition was once largely hidden, but it is now something doctors can often detect and manage much earlier.